- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07620821
VR for Cataract Anxiety Lowering Management--A RCT Study (VR-CALM)
August 1, 2026 updated by: Peiyao Jin, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
A Randomized Controlled Study of Virtual Reality Simulation of Intraoperative Audiovisual Experience to Reduce Anxiety in Cataract Surgery Patients
Cataract is currently the leading cause of blindness globally, and surgery is the only effective treatment.
With the advancement of medical technology, cataract surgery is usually performed under topical anesthesia, which means patients will be awake during the procedure, able to see the light from the surgical lamp and hear the sounds of surgical instruments being operated.
Some patients may feel nervous or scared due to unfamiliarity with the surgical process, which may lead to increased blood pressure, rapid heartbeat, and even affect their cooperation during the surgery.Virtual reality (VR) technology is a new multimedia technology.
By wearing VR glasses, patients can immerse themselves in a virtual world and see and hear realistic scenes.
Through this study, the investigators aim to investigate whether allowing cataract patients to "experience" a surgical procedure in advance through VR glasses before cataract surgery can help alleviate their nervousness during the actual surgery.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
223
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China, 200080
- Shanghai General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosed with cataracts in one or both eyes, and planning to undergo surgical treatment
- Voluntarily participate in this trial and sign the informed consent form.
Exclusion Criteria:
- History of previous ophthalmic surgery
- Suffering from severe hearing impairment, unable to comprehend VR video content.
- Those who suffer from cognitive dysfunction or mental illness and are unable to cooperate in completing the scale assessment.
- Suffering from severe macular diseases, glaucoma, or other ocular diseases that may affect surgery or interfere with the assessment of tension level.
- Assessed as intolerant to topical anesthesia for the surgery.
- History of motion sickness, severe vertigo, or intolerance to VR video viewing (such as claustrophobia).
- Other situations where the researcher deems the participant unsuitable for participation in this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: VR Intervention Group
30 participants receive virtual reality simulation of intraoperative audiovisual experience before the surgery.
|
This Virtual reality video simulates the audiovisual experience of phacoemulsification (Phaco and IOL) surgery
Other Names:
|
|
No Intervention: Usual Care Group (No VR)
Participants with conventional preoperative instructions (no VR video)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The change of anxiety level evaluated by numerical rating scale (NRS)
Time Frame: collected before the intervention (VR video or conventional preoperative instructions) , immediately before the surgery, and immediately after the surgery
|
The change of participants self-reported anxiety levels before and during the surgery, evaluated by numerical rating scale (NRS), from 0 (no anxiety) to 10 (highest anxiety)
|
collected before the intervention (VR video or conventional preoperative instructions) , immediately before the surgery, and immediately after the surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The change of Heart Rate
Time Frame: Before the intervention (VR video or conventional preoperative instructions) , immediately before the surgery, and during phacoemulsification.
|
The change of heart rates before and during the surgery
|
Before the intervention (VR video or conventional preoperative instructions) , immediately before the surgery, and during phacoemulsification.
|
|
The change of blood pressure
Time Frame: collected before the intervention (VR video or conventional preoperative instructions) , immediately before the surgery, and during phacoemulsification
|
The change of blood pressure before and during the surgery
|
collected before the intervention (VR video or conventional preoperative instructions) , immediately before the surgery, and during phacoemulsification
|
|
Pain level
Time Frame: collected immediately after the surgery
|
Intraoperative participants self-reported pain level using numerical rating scale (NRS), from 0 (no pain) to 10 (highest pain)
|
collected immediately after the surgery
|
|
Patients' cooperation level
Time Frame: collected immediately after the surgery
|
The numerical rating scale (NRS) score of patient cooperation level assessed by the surgeon, from 0 (very bad cooperation) to 5 (very good cooperation)
|
collected immediately after the surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2026
Primary Completion (Actual)
July 30, 2026
Study Completion (Actual)
July 30, 2026
Study Registration Dates
First Submitted
May 27, 2026
First Submitted That Met QC Criteria
May 27, 2026
First Posted (Actual)
June 2, 2026
Study Record Updates
Last Update Posted (Actual)
August 4, 2026
Last Update Submitted That Met QC Criteria
August 1, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2026KS258 (Other Identifier: Shanghai General Hospital)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.